Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets

J. R. Sheu, W. C. Hung, Y. C. Kan, Y. M. Lee, M. H. Yen

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

In this study, Escherichia coli lipopolysaccharide (LPS) dose- dependently (100-300 μg/ml) and time-dependently (10-60 min) inhibited platelet aggregation in human platelets stimulated by agonists. LPS also dose-dependently inhibited the phosphoinositide breakdown and the intracellular Ca+2 mobilization in human platelets stimulated by collagen. LPS (300 μg/ml) also significantly inhibited the thromboxane A2 formation stimulated by collagen in human platelets. Moreover, LPS (100-300 μg/ml) dose-dependently decreased the fluorescence of platelet membranes tagged with diphenylhexatrience. In addition, LPS (200 and 300 μg/ml) significantly increased the formation of cyclic GMP but not cyclic AMP in platelets. LPS (200 μg/ml) also significantly increased the production of nitrate within a 30 min incubation period. Rapid phosphorylation of a platelet protein of M(r) 47 000, a marker of protein kinase C activation, was triggered by phorbol- 12-13-dibutyrate (PDBu, 50 nM). This phosphorylation was markedly inhibited by LPS (200 μg/ml) within a 30 min incubation period. These results indicate that the antiplatelet activity of LPS may be involved in two important pathways. (1) LPS may induce conformational changes in the platelet membrane, leading to change in the activity of phospholipase C, (2) LPS also activated the formation of nitric oxide (NO)/cyclic GMP in human platelets, resulting in inhibition of platelet aggregation. Therefore, LPS-mediated alteration of platelet function may contribute to bleeding diathesis in septicaemic and endotoxaemic patients.

Original languageEnglish
Pages (from-to)29-38
Number of pages10
JournalBritish Journal of Haematology
Volume103
Issue number1
DOIs
Publication statusPublished - 1998

Fingerprint

Lipopolysaccharides
Blood Platelets
Escherichia coli
Cyclic GMP
Platelet Aggregation
Collagen
Phosphorylation
Phorbol 12,13-Dibutyrate
Thromboxane A2
Membranes
Disease Susceptibility
Type C Phospholipases
Phosphatidylinositols
Cyclic AMP
Nitrates
Protein Kinase C
Nitric Oxide
Fluorescence
Hemorrhage

Keywords

  • LPS
  • Membrane fluidity
  • Nitric oxide
  • Phosphoinositide breakdown
  • Protein kinase C.

ASJC Scopus subject areas

  • Hematology

Cite this

Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets. / Sheu, J. R.; Hung, W. C.; Kan, Y. C.; Lee, Y. M.; Yen, M. H.

In: British Journal of Haematology, Vol. 103, No. 1, 1998, p. 29-38.

Research output: Contribution to journalArticle

Sheu, J. R. ; Hung, W. C. ; Kan, Y. C. ; Lee, Y. M. ; Yen, M. H. / Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets. In: British Journal of Haematology. 1998 ; Vol. 103, No. 1. pp. 29-38.
@article{a0d5dd8d16a64596828a09a9c95d2f83,
title = "Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets",
abstract = "In this study, Escherichia coli lipopolysaccharide (LPS) dose- dependently (100-300 μg/ml) and time-dependently (10-60 min) inhibited platelet aggregation in human platelets stimulated by agonists. LPS also dose-dependently inhibited the phosphoinositide breakdown and the intracellular Ca+2 mobilization in human platelets stimulated by collagen. LPS (300 μg/ml) also significantly inhibited the thromboxane A2 formation stimulated by collagen in human platelets. Moreover, LPS (100-300 μg/ml) dose-dependently decreased the fluorescence of platelet membranes tagged with diphenylhexatrience. In addition, LPS (200 and 300 μg/ml) significantly increased the formation of cyclic GMP but not cyclic AMP in platelets. LPS (200 μg/ml) also significantly increased the production of nitrate within a 30 min incubation period. Rapid phosphorylation of a platelet protein of M(r) 47 000, a marker of protein kinase C activation, was triggered by phorbol- 12-13-dibutyrate (PDBu, 50 nM). This phosphorylation was markedly inhibited by LPS (200 μg/ml) within a 30 min incubation period. These results indicate that the antiplatelet activity of LPS may be involved in two important pathways. (1) LPS may induce conformational changes in the platelet membrane, leading to change in the activity of phospholipase C, (2) LPS also activated the formation of nitric oxide (NO)/cyclic GMP in human platelets, resulting in inhibition of platelet aggregation. Therefore, LPS-mediated alteration of platelet function may contribute to bleeding diathesis in septicaemic and endotoxaemic patients.",
keywords = "LPS, Membrane fluidity, Nitric oxide, Phosphoinositide breakdown, Protein kinase C.",
author = "Sheu, {J. R.} and Hung, {W. C.} and Kan, {Y. C.} and Lee, {Y. M.} and Yen, {M. H.}",
year = "1998",
doi = "10.1046/j.1365-2141.1998.00938.x",
language = "English",
volume = "103",
pages = "29--38",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets

AU - Sheu, J. R.

AU - Hung, W. C.

AU - Kan, Y. C.

AU - Lee, Y. M.

AU - Yen, M. H.

PY - 1998

Y1 - 1998

N2 - In this study, Escherichia coli lipopolysaccharide (LPS) dose- dependently (100-300 μg/ml) and time-dependently (10-60 min) inhibited platelet aggregation in human platelets stimulated by agonists. LPS also dose-dependently inhibited the phosphoinositide breakdown and the intracellular Ca+2 mobilization in human platelets stimulated by collagen. LPS (300 μg/ml) also significantly inhibited the thromboxane A2 formation stimulated by collagen in human platelets. Moreover, LPS (100-300 μg/ml) dose-dependently decreased the fluorescence of platelet membranes tagged with diphenylhexatrience. In addition, LPS (200 and 300 μg/ml) significantly increased the formation of cyclic GMP but not cyclic AMP in platelets. LPS (200 μg/ml) also significantly increased the production of nitrate within a 30 min incubation period. Rapid phosphorylation of a platelet protein of M(r) 47 000, a marker of protein kinase C activation, was triggered by phorbol- 12-13-dibutyrate (PDBu, 50 nM). This phosphorylation was markedly inhibited by LPS (200 μg/ml) within a 30 min incubation period. These results indicate that the antiplatelet activity of LPS may be involved in two important pathways. (1) LPS may induce conformational changes in the platelet membrane, leading to change in the activity of phospholipase C, (2) LPS also activated the formation of nitric oxide (NO)/cyclic GMP in human platelets, resulting in inhibition of platelet aggregation. Therefore, LPS-mediated alteration of platelet function may contribute to bleeding diathesis in septicaemic and endotoxaemic patients.

AB - In this study, Escherichia coli lipopolysaccharide (LPS) dose- dependently (100-300 μg/ml) and time-dependently (10-60 min) inhibited platelet aggregation in human platelets stimulated by agonists. LPS also dose-dependently inhibited the phosphoinositide breakdown and the intracellular Ca+2 mobilization in human platelets stimulated by collagen. LPS (300 μg/ml) also significantly inhibited the thromboxane A2 formation stimulated by collagen in human platelets. Moreover, LPS (100-300 μg/ml) dose-dependently decreased the fluorescence of platelet membranes tagged with diphenylhexatrience. In addition, LPS (200 and 300 μg/ml) significantly increased the formation of cyclic GMP but not cyclic AMP in platelets. LPS (200 μg/ml) also significantly increased the production of nitrate within a 30 min incubation period. Rapid phosphorylation of a platelet protein of M(r) 47 000, a marker of protein kinase C activation, was triggered by phorbol- 12-13-dibutyrate (PDBu, 50 nM). This phosphorylation was markedly inhibited by LPS (200 μg/ml) within a 30 min incubation period. These results indicate that the antiplatelet activity of LPS may be involved in two important pathways. (1) LPS may induce conformational changes in the platelet membrane, leading to change in the activity of phospholipase C, (2) LPS also activated the formation of nitric oxide (NO)/cyclic GMP in human platelets, resulting in inhibition of platelet aggregation. Therefore, LPS-mediated alteration of platelet function may contribute to bleeding diathesis in septicaemic and endotoxaemic patients.

KW - LPS

KW - Membrane fluidity

KW - Nitric oxide

KW - Phosphoinositide breakdown

KW - Protein kinase C.

UR - http://www.scopus.com/inward/record.url?scp=0031685235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031685235&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.1998.00938.x

DO - 10.1046/j.1365-2141.1998.00938.x

M3 - Article

C2 - 9792285

AN - SCOPUS:0031685235

VL - 103

SP - 29

EP - 38

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -